Programme
Updated 8 September 2009
Thursday Sept 17 |
|
|
11:00-18:00 |
Registration |
|
13:00-15:00 |
Satellite symposium I (120 min): Vascular calcification (VC) - a major threat in CKD Chair: Peter Stenvinkel and Gerhard London
Q&A 20 min |
|
15:00-16:00 |
Coffe break |
|
16:00-18:00 |
Satellite symposium II: Genecure project: CVD in CKD - Impact of genetics and epigenetics Chair: Gerjan Navis, Paul Brenchley and Martin Schalling
|
|
19:00-21:00 |
Welcome reception at City Hall |
|
|
|
Friday Sept 18 |
|
|
09:00-9:15 |
Opening remarks |
|
09:15-11:00 |
Symposium I: "From renal physiology to optimal blood purification" Chair: Bob Zietze and Peter Barany
Q&A 15 min |
|
11:00-11:30 |
Coffe break |
|
11:30-12.15 |
ISBP Award lecture |
|
12:15-13:00 12:15-12:23
|
Free communications part I, Metabolism/Clinical I (abstract O1-O5) O1 Vitamin K2 Supplementation Reduces the Elevated Inactive Form of the Calcification Inhibitor Matrix Gla Protein in Hemodialysis Patients (Thilo Krueger, Germany) O2 Microinflammation and AKT Phoshorylation Play a Different Role on Muscle Cell Apoptosis and Proteolysis in Uremia (Irene Mannucci, Italy) O3 Development and Validation of a General Population Renal Risk Score (Nynke Halbesma, Netherlands) O4 Modulators of Angiogenesis, PIGF and sFlt-1, Predict Mortality in Prevalent Hemodialysis Patients (Tetsu Miyamoto, Sweden) O5 Endogenous Anti-Fibrotic Proteins: Novel Therapy for the Treatment and Prevention uf Chronic Kidney Disease (Bruce Riser, United States) |
|
13:00-14:00 |
Lunch and Poster session I, Hemodialysis (abstract P21-P36) |
|
14:00-14:45 |
Poster session II, Peritoneal Dialysis (abstract P37-P52) |
|
14:45-15:30 14:45-14:53
|
Free communications part II, Metabolism/Clinical II (abstract O6-O10) O6 Detection of Proximal Coronary Stenosis by High Resolution Coronary MR Angiography in CKD Patients (Georg Schlieper, Germany) O7 Is Fetuin-A a Mortality Risk Factor in Dialysis Patients or a Mere Risk Marker? A Mendelian Randomization Approach (Marion Verduijn, Netherlands) O8 The Novel Adipokine Chemerin is Related to Uremic Dysmetabolism and Mortality in End-Stage Renal Disease Patients (Tae Yamamoto, Sweden) O9 Dinucleoside Polyphosphates: Newly Detected Uremic Compounds with an Impact on Leukocyte Oxidative Burst (Eva Schepers, Belgium) O10 Osteoprotegerin Expression in Fat Tissue: Evidence for Fat-Bone Cross-talk (Anna Witasp, Sweden) |
|
15:30-16:00 |
Coffee break |
|
16:00-18:00 |
Lee Henderson symposium "Fluid status in the dialysis patient" Chair: Bengt Lindholm and Ingrid Ledebo
Q&A 20 min |
|
18:00-19:00 |
Business meeting |
|
20:00-23:00 |
Friday Night Dinner or Free evening |
|
|
|
Saturday Sept 19 |
|
|
09:00-18:00 |
Registration |
|
09:00-11:00 |
Symposium III "Central and autonomous nervous system alterations in the dialysis patient" Chair: Salvatore Di Gulio and Olof Heimbürger
Q&A 20 min |
|
11:00-11:30 |
Coffee break |
|
11:30-12:00 |
Invited lecture Chair: Peter Stenvinkel
Q&A 5 min |
|
12:00-13:00 |
Lunch and Poster session III, Metabolism (abstract P53-P68) |
|
13:00-13:45 |
Poster session IV, Clinical (abstract P69-P84) |
|
13:45-14:30 13:45-13:53
|
Free communications III, Hemodialysis (abstract O11-O15) O12 RAGE Gene (AGER) Polymorphisms and Mortality of Chronic Hemodialysis Patients (Vladimir Tesar, Czech Republic) O13 Evolution of Plasma BNP Levels during the First Months of Hemodialysis Treatment (Charles Chazot, France) O14 Albumin Permeability and Hemodiafiltration do not Affect Removal Rates of Protein-bound Uremic Toxins (Horst-Dieter Lemke, Germany) O15 Validation of Longitudinal Vector Analysis of Body Composition with Deuterium Dilution in Haemodialysis Patients (Cian Chan, United Kingdom) |
|
14:30-15:15 14:30-14:38
15:06-15:15
|
Free communications IV, Peritoneal Dialysis (abstract O16-O20) O17 Large Increases in Net Ultrafiltration (UF) by Raising PD Fluid Colloid Osmotic Pressure (COP) (Bengt Rippe, Sweden) O18 Pioglitazone Attenuates Dysmetabolism and Reduces Inflammation in PD Patients. A Randomized, Cross-over Trial (Yun Li, China) O19 A Damaged Glycocalyx in Peritoneal Dialysis Patients? (Carmen A Vlahu, Netherlands) O20 Effects of High Glucose on The Expression of VEGF and its Receptors in Rat Peritoneal Mesothelial Cells (Qunying Guo, China) |
|
15:15-15:45 |
Coffee break |
|
15:45-17:45 |
Symposium IV "Infection and immune dysfunction in dialysis patients" Chair: Raymond Vanholder and Joerg Vienken
Q&A 20 min |
|
17:45-18:00 |
Closing remarks (Gerhard Lonneman) |
|
19:00-23:00 |
Nobel museum |
Posters
Poster session I, Hemodialysis (abstract P21-P36), Friday September 18, 13:00-14:00
Chair: Lems Jerin, Frank van der Sande, Stefan Jacobson
P21 New Real-time System to Calculate Blood Pressure from Fistular Bruit Monitored During Hemodialysis (Sakae Omura, Japan)
P22 On-Line Haemodiafiltration: TMP Ultracontrol vs. UF Control in the Long Term (Giovanni Calabrese, Italy)
P23 Physical Force Parameters for Disconnecting External Dialysis Lines From Internal Double-Lumen Catheters: Risks of Breakage at the Joint (Yoshimitsu Takahashi, Japan)
P24 Development of Hemodialysis Accident Simulator System (Yoshiaki Nishite, Japan)
P25 A Reagent-Free Urea Monitor Based on Chemiluminescence for the Evaluation of Hemodialysis Efficiency (Tohru Okabayashi, Japan)
P26 Micro Embolies by Air Enter the Patient During Haemodialysis (Bernd Stegmayr, Sweden)
P27 Comparison of Different Test Systems to Assess Microbiological Purity of Water and Dialysate (Benjamin Stoelck, Berlin)
P28 Examination Of Metals In Ro Water (Fujio Nakamura, Japan)
P29 The Effect of Higher Dialysis Dosing in Critical Ill With AKI and Dialysis Patients (Hideki Kawanishi, Japan)
P30 Research on Oxygen Inhalation and its Effect on Hemodilution (Yoshihiro Tange, Japan)
P31 Improvement of Left Ventricular Synchronicity Assessed by Tissue Synchronization Imaging after a Single HD Session (Shirley Hayashi, Sweden)
P32 Determinants of Pre-Dialysis Levels and Intra-Dialytic Rises of Cardiac Troponin T (cTnT) Levels (Solmaz Assa, Netherlands)
P33 Tandum Cryofiltration Apheresis and Hemodialysis (Ghodrat Siami, United States)
P34 Selective Immunoglobulins Apheresis with Ig Adsopak (Antanas Griskevicius, Lithuania)
P35 Specific Removal of C-Reactive Protein (CRP) from Blood after Experimental Acute Myocardial Infarction (AMI) (Ahmed Sheriff, Germany)
P36 In Vitro Investigations of Free Light Chain Removal by High Cut-Off Hemodialysis (Markus Storr, Germany)
Poster session II, Peritoneal Dialysis (abstract P37-P52), Friday September 18, 14:00-14:45
Chair: Ken Leypoldt, Simon Davies, Olof Heimburger
P37 Membrane Transport of Ion Mixture: Mathematical Modeling (Magda Galach, Poland)
P38 Mathematical Modeling of Glucose-Insulin Regulation During Peritoneal Dialysis with Glucose-Based Fluids (Magda Galach, Poland)
P39 Kinetics of Osmotic Ultrafiltration and Glucose Transport during Peritoneal Dialysis: Distributed Modeling (Joanna Stachowska-Pietka, Poland)
P40 24-Hour Ultrafiltration (UF) Efficiency and Sodium (Na) Removal with Bimodal (Combined Glucose and Icodextrin) Solutions (John K Leypoldt, United States)
P41 Peritoneal Dialysis (PD) Prescription Factors Influence Phosphorus (P) and Calcium (Ca) Control (Karina Lopes, Portugal)
P42 Glucose Absorption and Daily Ultrafiltration in Patients on Continuous Ambulatory Peritoneal Dialysis (CAPD) (Ramón Paniagua, Mexico)
P43 Different Daily Schedules of Dialysis Fluids in CAPD Patients: Evaluation of Adequacy (Ramón Paniagua, Mexico)
P44 Daily Ultrafiltration with Different Overnight Dialysis Fluids in Patients on Continuous Ambulatory Peritoneal Dialysis (Ramón Paniagua, Mexico)
P45 Genetic Factors Influence Small Solute Transport at Baseline and During Follow-up in PD Patients (Annemieke Coester, Belgium)
P46 Longitudinal Analysis of Fluid and Solute Transport: A More Biocompatible Versus a Conventional Peritoneal Dialysis Solution (Annemieke Coester, Belgium)
P47 Inflammatory Cytokine Profile and Interaction with Solute Transport in Peritoneal Dialysis Patients within the Global Fluid Study (Mark Lambie, United Kingdom)
P48 Pro-BNP, ECW and Peritoneal Sodium Balance on CAPD and APD
Gallar Paloma, Spain
P49 Important Differences in Peritoneal Equilibration Test Results (Anneleen Pletinck, Belgium)
P50 Impact of Oral Sulodexide in a Rat Model of Peritoneal Perfusion (Anneleen Pletinck, Belgium)
P51 The Effects of Colchicine on Peritoneal Alterations Induced by Hypertonic PD Solution (Soner Duman, Turkey)
P52 The Effects of Aldosterone Inhibition on Peritoneal Membrane Derangements in Encapsulated Peritoneal Sclerosis (Devrim Bozkurt, Turkey)
Poster session III, Metabolism (abstract P53-P68), Saturday September 19, 12:00-13:00
Chair: Andre Kaplan, Simon Davies, Giacomo Garibotto
P53 Good Microdialysate yield an Reliable Urea Recovery Using Dextran 40 For Interstitial Microdialysis In Uremic Subjects (Leonard Ebah, United Kingdom)
P54 Indoxyl Sulphate induces Oxidative Stress and Expression of Osteoblast-specific Proteins in Vascular Smooth Muscle Cells (Toshimitsu Niwa, Japan)
P55Biological Activity of Circulating Plasma Exosomes in Acute and Chronic Renal Failure: Identification of New Uremic Toxins? (Vincenzo Cantaluppi, Italy)
P56 Plasma Ghrelin Relates with Nutritional Markers and Survival in Maintenance Hemodialysis Patients (Sung-Eun Hu, Republic of Korea)
P57 Renal and Extra-Renal Handling of ihe Antioxidant Glutathione and its Related Peptides in Humans (Björn Anderstam, Sweden)
P58 Glutathione (GSH) Degradation in Skeletal Muscle of Patients with Chronic Kidney Disease (CKD) (Alessandro Valli, Italy)
P59 Cholesterol Concentration and Short-term Versus Long-Term Outcome in Incident Dialysis Patients (Michal Chmielewski, Poland)
P60 Elevated Visfatin/NAMPT Correlates with Anorexia and Reduced Fasting Serum Amino Acids in CKD Patients (Juan Jesus Carrero, Sweden)
P61 Bone Mineral Density in Relation to Fat Mass and Lean Body Mass in Advanced Chronic Kidney Disease Patients (Sun-Hee Park, Sweden)
P62 Estrogen and Bone Mineral Density in Postmenopausal Hemodialysis Patients (Ayumu Nakashima, Japan)
P63 Vitamin D Deficiency in Dialysis Patients: Impact of Dialysis Modality and Implications on Outcome (Carolina Gracia, Spain)
P64 Transition of Serum Fibroblast Growth Factor-23 Levels in Recipients with Renal Osteopathy after Renal Transplantation (Tokumoto Tadahiko, Japan)
P65 Metabolic Implications of Abdominal Fat Accumulation in Hemodialysis Patients (Antonio Carlos Cordeiro, Sweden)
P66 Increasing Frequency of High Flux Dialyzer Improved Insulin Resistance in Maintenance Hemodialysis Patients (Huang Tao-Min, Taiwan)
P67 Effect of Online Hemodiafiltration on Oxidative Stress and Microinflammation (Paik Seong Lim, Taiwan)
P68 The Role of Uncoupling Protein 2 Exon 8 Insertion/deletion Polymorphism in Metabolic Disorder in PD Patients (Tongying Zhu, China)
Poster session IV, Clinical (abstract P69-P84), Saturday September 19, 13:00-13:45
Chair: Victor Gura, Yoshiaki Takemoto, Peter Barany
P69 Peritonitis and Technique Survival in CAPD Patients with and without Catheter Related and Mechanical Complications (Narayan Prasad, India)
P70 Comparative Study for PD Catheter Implant by Percutaneous Techinique, Guideded by Radioscopy and by Surgical Traditional Approach (Marcelo Mazza do Nascimento, Brazil)
P71 Temporal Trends in Hospitalization Rates on Peritoneal Dialysis: Single Centre Experience during 24 Years (Sofia Rocha, Portugal)
P72 Confounding Effect of Malnutrition and Comorbidities on Survival of CAPD Patients (Narayan Prasad, India)
P73 Low Levels of IgM Antibodies against Phosphorylcholine-A increase Mortality Risk in Patients Undergoing Hemodialysis (Xiang Hua, Sweden)
P74 Chronic Periodontitis and Inflammatory Markers in Chronic Kidney Disease Patients (Effie Ioannidou, United States)
P75 Diuretics on Hospital Mortality in Postoperative Patients Receiving Acute Dialysis (Huang Tao-Min, Taiwan)
P76 Handgrip Strength - A Novel Predictor for Heart Failure in Chronic Dialysis Patients (Angela Yee-Moon Wang, Hong Kong)
P77 The Prevalence of Intraventricular Dyssynchrony, Detected by Tissue Synchronization Imaging, In HD, PD and CKD Patients Stages 3 and 4 (Shirley Hayashi, Sweden)
P78 The Prevalence of Right Ventricular Dysfunction in CKD and Dialysis Patients: A Comparative Study (Shirley Hayashi, Sweden)
P79 Cardiac Dysfunction Associated with Hypertension with or without Left Ventricular Hypertrophy in CKD and Normal Renal Function (Kay Tan, United Kingdom)
P80 Heart Rate Variability Assessed by Fractal Dimension during Haemodialysis
(Frantisek Lopot, Czech Republic)
P81 The Association between eGFR and Clinical Parameters at the Timing of Dialysis Induction in Japanese CKD Stage 5 Patients (Sawako Kato, Japan)
P82 Glomerular Filtration Rate Estimated by Biolectrical Impedance Analysis is so Accurate as Modified of Diet in Renal Disease Formula (Secundino Cigarran, Spain)
P83 Limits of an Optimal Correcion of Renal Anemia in Hemodialysis Patients (Conrad Baldamus, Germany)
P84 Ferritin Iron Content and Hepcidin in Chronic Kidney Disease Patients (Peter Barany, Sweden)
